ArticleFrontiers in immunology2017

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Stephan Kloess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.